2026-W46 · Nov 9–Nov 15 · Company · Profile · published
Waters company profile · liquid chromatography, mass spectrometry & lab instruments · history · financial snapshot · S&P 500 rank #251 · 沃特斯公司業務歷史財務與標普500地位
SNAPSHOT
| Ticker | WAT (NYSE) |
| Company | Waters Corporation |
| GICS sector / industry | Health Care (XLV) / Life Sciences Tools & Services |
| S&P 500 rank (by weight) | #251 · 0.07% (Nov 2, 2026) |
| Sector rank (by S&P 500 weight) | #32 in Health Care (Nov 2, 2026) |
| Headquarters | Milford, Massachusetts |
| Founded | 1958, in Milford, Massachusetts |
| CEO | Udit Batra (president and CEO since Sep 1, 2020) |
| Market cap | $45.46B (Nov 2, 2026) |
| SEC filings | EDGAR — CIK 0001000697 |
WHAT IT DOES
Waters makes analytical instruments and software used to measure what is in a sample: liquid chromatography, mass spectrometry and related consumables and services for pharmaceutical, food, environmental and materials laboratories.
Pharmaceutical customers are the largest buyer class, followed by industrial accounts and academic and government labs. The business is a classic razor-and-blade model: instruments placed in labs generate recurring consumables and service revenue.
FY2025 total net sales rose 7.0% to $3,165.3M, operating income was $802.6M and net income was $642.6M, with diluted EPS of $10.76. In 2025, sales grew 10% in both China and Europe and 3% in the United States. FY2025 interest expense includes about $16M of financing costs incurred on behalf of SpinCo in connection with the BDS Business Acquisition financing.
SALES BY CUSTOMER CLASS — FY2025
| Segment | Net sales | Share | YoY |
|---|---|---|---|
| Pharmaceutical | $1,873.4M | 59.2% | — |
| Industrial | $961.2M | 30.4% | — |
| Academic & Government | $330.7M | 10.4% | — |
HISTORY
| Year | Milestone |
|---|---|
| 1958 | Waters founded in Massachusetts. |
| 1995 | Initial public offering on the New York Stock Exchange. |
| 2023 | Acquires Wyatt Technology, adding light-scattering instruments. |
| 2025 | FY2025 net sales $3,165.3M, up 7.0%, with growth in China and Europe. |
COMPETITIVE POSITION
FINANCIAL SNAPSHOT — FY2025
| Total net sales | $3,165.3M (+7.0% YoY, vs $2,958.4M) |
| Operating income | $802.6M |
| Net income | $642.6M |
| Diluted EPS | $10.76 |
KEY RISKS
WHY IT MATTERS FOR THE S&P 500
Waters is the analytical-instrument pure play in the index: its order trends read directly on pharmaceutical R&D and quality-control spending.
At S&P 500 rank #251 with a 0.07% weight, it represents life sciences tools and services inside Health Care.
SOURCES & METHODOLOGY
| Market data | Slickcharts S&P 500 by weight (rank, weight, price — Nov 2, 2026 crawl) · StockAnalysis (market cap — Nov 2, 2026 crawl, single source) |
| Financials | Waters Form 10-K FY2025 (filed Feb 23, 2026), consolidated statements and customer-class split |
| Sector classification | GICS via the List of S&P 500 companies (Wikipedia) |
| Library data | SPXSet logo library, compiled from company official websites, filings, or Wikipedia; as company logos are dynamic corporate information, no 100% guarantee is made for the graphics. SPXSet chart library, monthly bars, compiled from Yahoo public information. |
Source: Yahoo Finance monthly bars, split-adjusted · Data as of Sep 30, 2026 (last closed month) · SPXSet.com
FINANCIALS
公司快照
| 股票代號 | WAT(NYSE) |
| 公司 | Waters Corporation |
| GICS 板塊/行業 | 健康護理(XLV)/Life Sciences Tools & Services |
| 標普500排名(按權重) | 第251名 · 0.07%(2026 年 11 月 2 日) |
| 板塊內排名(按標普500權重) | 健康護理第32名(2026 年 11 月 2 日) |
| 總部 | 麻省米爾福德 |
| 成立 | 1958年,麻省米爾福德 |
| 行政總裁 | Udit Batra(總裁兼行政總裁,2020年9月1日起) |
| 市值 | $45.46B(2026 年 11 月 2 日) |
| SEC 文件 | EDGAR — CIK 0001000697 |
業務概覽
沃特斯生產用於檢測樣本成分的分析儀器與軟件:液相色譜、質譜及相關耗材與服務,服務製藥、食品、環境與材料實驗室。
製藥客戶為最大買家類別,其次為工業客戶與學術及政府實驗室。業務屬典型「剃刀與刀片」模式:裝機儀器帶來經常性耗材與服務收入。
FY2025 總淨銷售額增長 7.0% 至 31.653 億美元,營運利潤 8.026 億美元,淨利潤 6.426 億美元,攤薄每股收益 10.76 美元。2025 年中國與歐洲銷售各增長 10%,美國增長 3%。FY2025 利息開支包含約 1,600 萬美元為 SpinCo 就 BDS 業務收購融資承擔的融資成本。
按客戶類別劃分的銷售額 — FY2025
| 板塊 | 淨銷售額 | 佔比 | 同比 |
|---|---|---|---|
| 製藥 | $1,873.4M | 59.2% | — |
| 工業 | $961.2M | 30.4% | — |
| 學術與政府 | $330.7M | 10.4% | — |
歷史沿革
| 年份 | 里程碑 |
|---|---|
| 1958 | 沃特斯於麻省成立。 |
| 1995 | 紐約證券交易所首次公開招股。 |
| 2023 | 收購 Wyatt Technology,增加光散射儀器。 |
| 2025 | FY2025 淨銷售額 31.653 億美元,同比增長 7.0%,中國與歐洲均增長。 |
競爭地位
財務快照 — FY2025
| 總淨銷售額 | $3,165.3M(同比 +7.0%,上年 $2,958.4M) |
| 營運利潤 | $802.6M |
| 淨利潤 | $642.6M |
| 攤薄每股收益 | $10.76 |
主要風險
對標普500的重要性
沃特斯是指數中的分析儀器純粹代表:其訂單趨勢直接反映製藥研發與質量控制開支。
標普500排名第251位、權重 0.07%,代表健康護理板塊內的生命科學工具與服務行業。
來源與方法
| 市場數據 | Slickcharts 標普500權重榜(排名、權重、價格——2026 年 11 月 2 日抓取)· StockAnalysis(市值——2026 年 11 月 2 日抓取,單一來源) |
| 財務 | 沃特斯 FY2025 10-K(2026 年 2 月 23 日提交),合併報表與客戶類別劃分 |
| 板塊分類 | GICS,據 S&P 500 公司清單(Wikipedia) |
| 圖庫數據 | SPXSet logo 庫,整理自企業官方網站、文件或維基百科;由於是企業自身動態資訊,不對圖形做百分百保證。SPXSet 圖表庫月線,整理自 Yahoo 公開資訊。 |
來源:Yahoo Finance 月 K(經拆股調整)· 數據截至 2026 年 9 月 30 日(最後已收月份)· SPXSet.com
財報
SPXSet in-house research — market structure, options and volatility. Not investment advice.
SPXSet 站內獨立研究,聚焦 SPX 市場結構、期權與波動率;內容不構成投資建議。
Entered 2026-11-01 20:08 · updated 2026-11-15 00:16 · rev 5